Form 4: Entera Bio CEO Receives Stock Grant
Insider Transaction (Form 4)
Miranda Jayne Toledano, Chief Executive Officer and a Director of Entera Bio Ltd., reported multiple transactions in common stock on July 14, 2026.
Summary
- Grant/award: acquired 347,567 Ordinary Shares, par value NIS 0.0000769 per share on July 14, 2026; holds 774,142 after (Direct).
- Grant/award: acquired 72,993 Ordinary Shares, par value NIS 0.0000769 per share on July 14, 2026; holds 847,135 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Miranda Jayne Toledano — Director, Officer (Chief Executive Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-14 | Grant/award | Ordinary Shares, par value NIS 0.0000769 per share | 347,567 | — | — | 774,142 |
| 2026-07-14 | Grant/award | Ordinary Shares, par value NIS 0.0000769 per share | 72,993 | — | — | 847,135 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-14 | Grant/award (347,567 shares) |
| 2026-07-14 | Grant/award (72,993 shares) |
Keywords
insider transaction, Form 4, ENTX, Entera Bio Ltd., neutral, Miranda Jayne Toledano
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.